Conditions

Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?

Pediatric patients with T2D have accelerated onset of hypertension, dyslipidemia, kidney disease, nerve disease, and diabetic retinopathy.

Recently completed research examines the effect of consistent cycling on all-cause and cardiovascular mortality.

Investigating whether a low-carb diet can lead to diabetes remission.

GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.

How has the pandemic affected the incidence of type 2 diabetes and other conditions such as Hyperosmolar Hyperglycemic Syndrome (HHS) within the younger population?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

Male, 72 years of age, type 2, insulin-requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of the workday, glucose elevated much higher than the reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy....

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.

Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19.